George J - Search Results

1

Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE⁻/⁻ mice.

Feige E, Yacov N, Salem Y, Levi I, Mendel I, Propheta-Meiran O, Shoham A, Hait-Darshan R, Polonsky O, George J, Harats D, Breitbart E. Feige E, et al. Among authors: george j. Atherosclerosis. 2013 Aug;229(2):430-9. doi: 10.1016/j.atherosclerosis.2013.06.005. Epub 2013 Jun 21. Atherosclerosis. 2013. PMID: 23880199 Free article.

2

Modified phospholipids as anti-inflammatory compounds.

Feige E, Mendel I, George J, Yacov N, Harats D. Feige E, et al. Among authors: george j. Curr Opin Lipidol. 2010 Dec;21(6):525-9. doi: 10.1097/MOL.0b013e32833f2fcb. Curr Opin Lipidol. 2010. PMID: 20827191 Review.

3

VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis.

Mendel I, Feige E, Yacov N, Salem Y, Levi I, Propheta-Meiran O, Shoham A, Ishai E, George J, Harats D, Breitbart E. Mendel I, et al. Among authors: george j. Clin Exp Immunol. 2014 Jan;175(1):126-37. doi: 10.1111/cei.12212. Clin Exp Immunol. 2014. PMID: 24116867 Free PMC article. Clinical Trial.

4

Antigen-tailored therapy based on the inflammatory theory of atherosclerosis.

Harats D, George J. Harats D, et al. Among authors: george j. Expert Rev Vaccines. 2004 Oct;3(5):605-11. doi: 10.1586/14760584.3.5.605. Expert Rev Vaccines. 2004. PMID: 15485340 Free article. Review.

5

A functional role for inducible costimulator (ICOS) in atherosclerosis.

Afek A, Harats D, Roth A, Keren G, George J. Afek A, et al. Among authors: george j. Atherosclerosis. 2005 Nov;183(1):57-63. doi: 10.1016/j.atherosclerosis.2005.03.040. Epub 2005 Jun 6. Atherosclerosis. 2005. PMID: 15941568

6

The effects of N-6 polyunsaturated fatty acid supplementation on the lipid composition and atherogenesis in mouse models of atherosclerosis.

George J, Mulkins M, Casey S, Schatzman R, Sigal E, Harats D. George J, et al. Atherosclerosis. 2000 Jun;150(2):285-93. doi: 10.1016/s0021-9150(99)00377-9. Atherosclerosis. 2000. PMID: 10856520

7

Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis.

Keren P, George J, Keren G, Harats D. Keren P, et al. Among authors: george j. Atherosclerosis. 2001 Aug;157(2):285-92. doi: 10.1016/s0021-9150(00)00685-7. Atherosclerosis. 2001. PMID: 11472727

8

Beta2-glycoprotein I and atherosclerosis.

Harats D, George J. Harats D, et al. Among authors: george j. Curr Opin Lipidol. 2001 Oct;12(5):543-6. doi: 10.1097/00041433-200110000-00010. Curr Opin Lipidol. 2001. PMID: 11561174 Review.

9

Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice.

Afek A, Harats D, Roth A, Keren G, George J. Afek A, et al. Among authors: george j. Exp Mol Pathol. 2004 Jun;76(3):219-23. doi: 10.1016/j.yexmp.2003.12.001. Exp Mol Pathol. 2004. PMID: 15126104

10

Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I.

George J, Yacov N, Breitbart E, Bangio L, Shaish A, Gilburd B, Shoenfeld Y, Harats D. George J, et al. Cardiovasc Res. 2004 Jun 1;62(3):603-9. doi: 10.1016/j.cardiores.2004.01.028. Cardiovasc Res. 2004. PMID: 15158153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,441 results

Search Page

Filters